Stratogene Pharma
dashboard
Today
Active
4
Ready
3
Open Dev.
1
Yield 30d
95.3%
OOS 30d
0.09%
Welcome back, Rajesh
Here's what's happening on the floor today.
Manufacturing Lines
Live status — 08 Jun 2026
Line 1
Solid Dosage — Compression & Filling
Active Batch
MET-C-0045
Metformin HCl 500mg Capsules🔵 Capsule
Stage: ⚙️ Filling
Started: 07 Jun 2026, 08:00 IST
Checks: 4 recorded · Pass Rate: 100%
Operator: Priya Sharma
Line 2
Solid Dosage — Compression & Strip Pack
Active Batch
IBU-0340
Ibuprofen 200mg Tablets💊 Tablet
Stage: ⚙️ Coating
Started: 02 Jun 2026, 08:00 IST
Checks: 45 recorded · Pass Rate: 100%
Operator: Sanjay Khanna
Line 3
Coating & Blister Pack
Active Batch
PAR-0124
Paracetamol 500mg Tablets💊 Tablet
Stage: ⚙️ Packing
Started: 03 Jun 2026, 06:00 IST
Checks: 3 recorded · Pass Rate: 67%
Operator: Priya Sharma
Line 4
Capsule Blister & Secondary Pack
Active Batch
IBU-C-0023
Ibuprofen 200mg Capsules🔵 Capsule
Stage: ⚙️ Packing
Started: 04 Jun 2026, 06:30 IST
Checks: 13 recorded · Pass Rate: 100%
Operator: Sanjay Khanna
Line 5
Liquid Manufacturing Suite
Active Batch
PAR-L-0012
Paracetamol Oral Suspension 250mg/5mL🧪 Liquid
Stage: 🧪 Compounding
Started: 07 Jun 2026, 11:30 IST
Checks: 4 recorded · Pass Rate: 100%
Operator: Priya Sharma
Avg Yield
GREEN95.3%
All products
OOS Rate
GREEN0.09%
2127 checks
Compliance
GREEN99.1%
Part 11 audit
Open Deviations
1
Attention Queue
5 itemsSorted by severity (CRITICAL first) · Last updated: 08 Jun 2026
🔴 1 Critical🟠 2 High🟡 1 Medium⚪ 1 Low
🔴 CRITICALFacility-wide
Self-inspection overdue
85 days since last inspection. Schedule M requires monthly self-inspection (≤30 days).
🟠 HIGHLine 1 / COMP-A
COMP-A calibration due in 15 days
Due 23 Jun 2026. Schedule now to avoid production interruption.
🟠 HIGHLine 2
Hold approval pending — PAR-0124
Fill Weight OOS (486.2 mg). Awaiting QA decision.
🟡 MEDIUMLine 1
Deviation Phase II in progress
DEV-MET-0891-002 — Phase II investigation due. CAPA pending.
⚪ LOWFacility-wide
Audit finding F-2026-06-001 open
MINOR finding from INSP-2026-06-05. Response due within 30 days.
Hold Approval Requests
- Approve HoldPAR-0124Requested by Amit Patel · Fill Weight Check #3 returned 486.2 mg (spec: 490-510 mg). Production stopped pending QA investigati…
Golden Batch benchmark
MET-0889 · Metformin HCl 500mg Tablets
Batch ID
MET-0889
Product
MET-500-T
Dates
21 May 2026 → 24 May 2026
Yield
96.5%
Zero deviations
| Metric | Current Month | Golden Batch | Δ | Verdict |
|---|---|---|---|---|
| Yield % | 96.2% | 96.5% | 0.29% | Slightly Higher |
| OOS Rate | 0.00% | 0.00% | 0% | Similar |
| Avg Cpk | 0.00 | 2.10 | 2.10 | Slightly Higher |
| Mean Fill Weight | 112.36 mg | 109.26 mg | 3.09 mg | Slightly Higher |
| Deviation Rate | 0.0% | 0.0% | 0% | Similar |
Comparison vs trailing 10 batches of MET-500-T. The Golden Batch is the best historical execution and is used as the calibration target for SPC limits.
🏆 Golden Capsule benchmark
MET-C-0042 · Metformin HCl 500mg Capsules
Batch
MET-C-0042
Line
Line 1
Dates
28 Apr 2026 → 30 Apr 2026
Yield
98.4%
Zero deviations
Best-yielding capsule batch in the trailing closed-batch window. Used as the calibration target for capsule fill weight SPC limits.
🏆 Golden Liquid Benchmark
PAR-L-0010 · Paracetamol Oral Suspension 250mg/5mL
Batch
PAR-L-0010
Line
Line 5
Dates
14 May 2026 → 16 May 2026
Yield
98.1%
Zero deviations
Best-yielding liquid batch in the trailing closed-batch window. Used as the calibration target for liquid pH and fill-volume SPC limits.
Yield & OOS trend (6 months)
Yield 77.8%OOS 0.09%
Equipment performance
Compression Machine A
Compression · Line 1 · Optimal · last PM 28 May
Compression Machine B
Compression · Line 2 · Calibration due Jun 8
Coating Pan
Coating · Line 3 · Optimal · pan rotation nominal
Bottle Filling Line
Packaging · Bottle · Optimal · induction sealer verified
Strip Packing Machine
Packaging · Strip · Maintenance due
Blister Packer A
Packaging · Blister · Optimal
Blister Packer B
Packaging · Blister · Optimal
Product performance
| Product | Batches | Avg Yield | OOS Rate | Cpk | |
|---|---|---|---|---|---|
Ibuprofen 200mg Tablets IBU-200-T | 40 | 96.3% | 0.00% | 0.00 | Incapable |
Metformin HCl 500mg Tablets MET-500-T | 41 | 95.9% | 0.18% | 0.00 | Incapable |
Paracetamol 500mg Tablets PAR-500-T | 37 | 96.8% | 0.20% | 0.00 | Incapable |
Metformin HCl 500mg Capsules MET-500-C | 10 | 87.5% | 0.00% | 0.00 | Incapable |
Ibuprofen 200mg Capsules IBU-200-C | 10 | 97.6% | 0.00% | 0.00 | Incapable |
Paracetamol Oral Suspension 250mg/5mL PAR-250-L | 9 | 86.5% | 0.00% | 0.00 | Incapable |
Ibuprofen Oral Suspension 100mg/5mL IBU-100-L | 8 | 97.4% | 0.00% | 0.00 | Incapable |
Open Deviations
View all- OpenOpenDEV-MET-0891-002Fill Weight OOS (485 mg, LSL 490 mg) — repeat investigation
Ready for Closure
| Batch | Product | Line | Status | Yield | |
|---|---|---|---|---|---|
| IBU-0340 | Ibuprofen 200mg Tablets | Line 2 | Ready for Closure | 96% | |
| IBU-C-0023 | Ibuprofen 200mg Capsules | Line 4 | Ready for Closure | 97.8% | |
| IBU-L-0008 | Ibuprofen Oral Suspension 100mg/5mL | Line 5 | Ready for Closure | 97.3% |
Audit Readiness🇮🇳 CDSCO
71/100🟡 PREP
71%
✅ 3 sections compliant
🟠 6 sections need attention
Next: 05 Aug 2026 (58 days)
Last: 15 Mar 2026 (82/100 ↘)
QMS Coverage
- Regulatory Philosophy✅
- Data Integrity✅
- Validation & Qualification🟠
- Quality Risk Management🟠
- Out of Specification (OOS)✅
